Eversheds Sutherland

We are only able to display limited information for this firm. We display more complete information for all of the following firms:

Co-heads Robert Copps, Michael Voynich and Ted Cominos lead Eversheds Sutherland’s private equity offering, which blends sponsor and investor side advice with a strong cross border reach across the firm’s wider platform. The teams activity leans toward broader private equity transactions and regulatory support.
Legal 500 Editorial commentary

Key clients

  • Azurity Pharmaceuticals
  • QHP Capital

Work highlights

Advised Azurity Pharmaceuticals and QHP Capital in their significant acquisition of Covis Pharma.